← Back to Search

Behavioural Intervention

Auditory Mirror Therapy for Tinnitus

N/A
Waitlist Available
Research Sponsored by Spaulding Rehabilitation Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 weeks
Awards & highlights

Summary

This trial tests special earmuffs that switch sounds between ears to help people with chronic tinnitus. The goal is to see if this can reduce their symptoms by changing how their brain processes sounds. Auditory mirror therapy (AMT) involves swapping sounds between ears to reduce tinnitus, similar to mirror box therapy used for phantom limb pain.

Who is the study for?
This trial is for adults aged 18-80 who have been experiencing chronic tinnitus, which means a constant ringing or noise in the ears, for more than three months. It's not specified if there are any specific exclusions other than age and duration of tinnitus.
What is being tested?
The study is testing Auditory Mirror Therapy (AMT) using special earmuffs that flip sounds from one ear to the other. The goal is to see if this can help reduce the symptoms of tinnitus.
What are the potential side effects?
Potential side effects aren't detailed here, but since AMT involves non-invasive auditory input redirection, significant side effects may be unlikely compared to drug treatments.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Tinnitus Functional Index (TFI)
Secondary study objectives
Change in Minimum Masking Level (MML) and residual inhibition (RI)
Change in Tinnitus Handicap Inventory (THI)
Change in Visual Analogue Scale (VAS)
Other study objectives
Auditory Mirror Therapy Questionnaire

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Auditory Mirror Therapy DeviceExperimental Treatment1 Intervention
Modified 3M Peltor Tactical 300 Electronic Hearing Protector. The modification consists of connecting the left microphone to the right microphone tab on the circuit board, and vice versa.
Group II: Sham Headphone DevicePlacebo Group1 Intervention
Non-Modified 3M Peltor Tactical 300 Electronic Hearing Protector

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for tinnitus include sound therapy, cognitive behavioral therapy (CBT), and medications. Sound therapy works by providing external noise to mask the tinnitus or by using devices that produce customized sounds to reduce the perception of tinnitus. CBT helps patients manage the emotional and psychological impact of tinnitus by changing their response to the condition. Medications may be used to treat underlying conditions or to alleviate symptoms such as anxiety or depression. The Auditory Mirror Earmuffs, which re-route auditory input to the opposite ears, aim to alter the brain's processing of sound, potentially reducing the perception of tinnitus. This approach matters for tinnitus patients as it offers a non-invasive method to modulate auditory input and may provide relief from the persistent and often distressing symptoms of tinnitus.

Find a Location

Who is running the clinical trial?

Spaulding Rehabilitation HospitalLead Sponsor
137 Previous Clinical Trials
10,967 Total Patients Enrolled
Harvard UniversityOTHER
233 Previous Clinical Trials
475,022 Total Patients Enrolled
~17 spots leftby Sep 2025